Header Logo

Connection

EMERSON PERIN to Middle Aged

Back to Details
This is a "connection" page, showing publications EMERSON PERIN has written about Middle Aged.
EMERSON PERIN
Connection Strength
0.552
Middle Aged
  1. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation. 2017 Apr 11; 135(15):1417-1428.
    View in: PubMed
    Score: 0.034
  2. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):169-177.
    View in: PubMed
    Score: 0.033
  3. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene Ther. 2016 Mar; 23(3):306-12.
    View in: PubMed
    Score: 0.031
  4. A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure. Circ Res. 2015 Aug 28; 117(6):576-84.
    View in: PubMed
    Score: 0.031
  5. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. Am Heart J. 2014 Jul; 168(1):88-95.e2.
    View in: PubMed
    Score: 0.028
  6. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012 Apr 25; 307(16):1717-26.
    View in: PubMed
    Score: 0.024
  7. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J. 2012 Mar; 163(3):415-21, 421.e1.
    View in: PubMed
    Score: 0.024
  8. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2011 Dec 01; 78(7):1060-7.
    View in: PubMed
    Score: 0.023
  9. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J. 2011 Jun; 161(6):1078-87.e3.
    View in: PubMed
    Score: 0.023
  10. Assessing intermediate coronary lesions: angiographic prediction of lesion severity on intravascular ultrasound. J Invasive Cardiol. 2007 Oct; 19(10):412-6.
    View in: PubMed
    Score: 0.018
  11. [Sustained improvement in symptoms and exercise capacity up to six months after autologous transendocardial transplantation of bone marrow mononuclear cells in patients with severe ischemic heart disease]. Arq Bras Cardiol. 2005 May; 84(5):360-6.
    View in: PubMed
    Score: 0.015
  12. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004 Sep 14; 110(11 Suppl 1):II213-8.
    View in: PubMed
    Score: 0.014
  13. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003 May 13; 107(18):2294-302.
    View in: PubMed
    Score: 0.013
  14. Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps. Tex Heart Inst J. 2003; 30(1):19-26.
    View in: PubMed
    Score: 0.013
  15. Left ventricular electromechanical mapping: preliminary evidence of electromechanical changes after successful coronary intervention. Am Heart J. 2002 Oct; 144(4):693-701.
    View in: PubMed
    Score: 0.013
  16. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002 Aug 20; 106(8):957-61.
    View in: PubMed
    Score: 0.013
  17. "Wireless" laser recanalization of chronic total coronary occlusions. J Invasive Cardiol. 2001 May; 13(5):401-5.
    View in: PubMed
    Score: 0.011
  18. Left ventricular electromechanical mapping: a case study of functional assessment in coronary intervention. Tex Heart Inst J. 2000; 27(3):253-6.
    View in: PubMed
    Score: 0.010
  19. Laser channels after percutaneous transmyocardial revascularization. Circulation. 1999 Apr 27; 99(16):2218.
    View in: PubMed
    Score: 0.010
  20. Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. Am Heart J. 2018 07; 201:54-62.
    View in: PubMed
    Score: 0.009
  21. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circ Res. 2018 02 02; 122(3):479-488.
    View in: PubMed
    Score: 0.009
  22. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Res Cardiol. 2017 01; 112(1):3.
    View in: PubMed
    Score: 0.008
  23. Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Tex Heart Inst J. 2016 Aug; 43(4):291-6.
    View in: PubMed
    Score: 0.008
  24. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Am Heart J. 2016 09; 179:142-50.
    View in: PubMed
    Score: 0.008
  25. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial. Cell Transplant. 2016; 25(9):1675-1687.
    View in: PubMed
    Score: 0.008
  26. Cardiac sarcoidosis. An unusual form of acute congestive cardiomyopathy. Tex Heart Inst J. 1995; 22(3):265-7.
    View in: PubMed
    Score: 0.007
  27. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res. 2015 Jan 02; 116(1):99-107.
    View in: PubMed
    Score: 0.007
  28. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circ Res. 2014 Oct 24; 115(10):867-74.
    View in: PubMed
    Score: 0.007
  29. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012 Dec 12; 308(22):2380-9.
    View in: PubMed
    Score: 0.006
  30. Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques. Tex Heart Inst J. 2012; 39(3):342-50.
    View in: PubMed
    Score: 0.006
  31. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011 Nov 16; 306(19):2110-9.
    View in: PubMed
    Score: 0.006
  32. Doppler echocardiography in 180 normally functioning St. Jude Medical aortic valve prostheses. Early and late postoperative assessments. Chest. 1991 Oct; 100(4):988-90.
    View in: PubMed
    Score: 0.006
  33. Determinants and outcomes of asystole during carotid artery stenting. J Endovasc Ther. 2011 Aug; 18(4):513-7.
    View in: PubMed
    Score: 0.006
  34. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011 Oct; 18(5):912-9.
    View in: PubMed
    Score: 0.006
  35. Comparison of dipyridamole-echocardiography with dipyridamole-thallium scintigraphy for the diagnosis of myocardial ischemia. Clin Nucl Med. 1991 Jun; 16(6):417-20.
    View in: PubMed
    Score: 0.006
  36. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011 Jan; 161(1):98-105.
    View in: PubMed
    Score: 0.006
  37. Rate-related left bundle branch block as a cause of non-ischemic chest pain. Cathet Cardiovasc Diagn. 1991 Jan; 22(1):45-6.
    View in: PubMed
    Score: 0.006
  38. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
    View in: PubMed
    Score: 0.005
  39. [Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]. Rev Esp Cardiol. 2008 Jun; 61(6):635-9.
    View in: PubMed
    Score: 0.005
  40. Predictors of carotid stent restenosis. Catheter Cardiovasc Interv. 2007 Apr 01; 69(5):673-82.
    View in: PubMed
    Score: 0.004
  41. Hyperexpansion of coronary stents and clinical outcomes. Tex Heart Inst J. 2006; 33(4):437-44.
    View in: PubMed
    Score: 0.004
  42. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation. 2005 Jul 26; 112(4):521-6.
    View in: PubMed
    Score: 0.004
  43. Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J. 2004; 31(3):214-9.
    View in: PubMed
    Score: 0.003
  44. Power thrombectomy in acute ischemic coronary syndromes. Angiology. 2003 Jul-Aug; 54(4):457-68.
    View in: PubMed
    Score: 0.003
  45. One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol. 2003 Jun 01; 91(11):1342-6.
    View in: PubMed
    Score: 0.003
  46. Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly? Tex Heart Inst J. 2003; 30(3):176-9.
    View in: PubMed
    Score: 0.003
  47. A sewing needle in the right ventricle. Tex Heart Inst J. 2000; 27(3):314-5.
    View in: PubMed
    Score: 0.003
  48. Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. Lasers Surg Med. 1998; 22(4):228-39.
    View in: PubMed
    Score: 0.002
  49. [Evaluation of post-intracoronary stent implant. Intravascular ultrasound versus quantitative angiography]. Arq Bras Cardiol. 1995 May; 64(5):439-46.
    View in: PubMed
    Score: 0.002
  50. Anomalous coronary arteries: angiographic findings in 80 patients. Int J Cardiol. 1992 Feb; 34(2):129-38.
    View in: PubMed
    Score: 0.002
  51. Detection of thrombus in an aneurysm of the ventricular septum. Am J Cardiol. 1989 Jun 15; 63(20):1533-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.